RVMD
Revolution Medicines, Inc.
There isn't enough reported data to score RVMD yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
RVMD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
RVMD's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
RVMD PE Valuation
RVMD has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
RVMD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Moderate | |
| Low |
Analysts expect RVMD's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
RVMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$9.15 | -$4.08 |
| Q2 2026 | -$8.86 | -$4.46 |
| Q1 2026 | -$7.11 | -$3.21 |
| Q4 2025 | -$5.95 | -$2.48 |
| Q3 2025 | -$5.07 | -$1.39 |
| Q2 2025 | -$4.40 | -$0.67 |
| Q1 2025 | -$3.90 | -$0.06 |
| Q4 2024 | -$3.47 | +$0.39 |
RVMD lost $9.15 per share over the past year, a bigger loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over RVMD on earnings quality, reporting a profit while its opponent remains loss making.
RVMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $742K | -95% |
| Q2 2023 | $3.8M | -58% |
| Q1 2023 | $7M | -7.4% |
| Q4 2022 | $15.3M | +62% |
| Q3 2022 | $3.4M | +205% |
| Q2 2022 | $9.1M | +4.8% |
| Q1 2022 | $7.6M | -25% |
| Q4 2021 | $9.5M | +8.1% |
RVMD's revenue is growing: $198M last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -189% | N/A |
| Q4 2023 | -24256% | -23854 points |
| Q2 2023 | -2845% | -2164 points |
| Q1 2023 | -1072% | -307 points |
| Q4 2022 | -403% | +157 points |
| Q3 2022 | -2280% | +2548 points |
| Q2 2022 | -681% | -169 points |
| Q1 2022 | -765% | -396 points |
RVMD's operating margin was −189% last quarter, up 214 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over RVMD on profitability, with a higher operating margin.
RVMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$419.3M | -$208.7M |
| Q2 2026 | -$389.6M | -$160.4M |
| Q1 2026 | -$355.7M | -$158M |
| Q4 2025 | -$276.2M | -$136.7M |
| Q3 2025 | -$210.7M | -$76.7M |
| Q2 2025 | -$229.2M | -$98.6M |
| Q1 2025 | -$197.7M | -$34M |
| Q4 2024 | -$139.5M | -$16.6M |
RVMD has burned cash in almost every quarter: −$1.4B over the past year, against −$777M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over RVMD on cash generation, producing positive trailing cash flow while its opponent burns cash.
RVMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +4.1M shares |
| 1 year | +14% | +25.7M shares |
| 3 years | +101% | +108M shares |
| 5 years | +193% | +142M shares |
| Available history | +489% | +178M shares |
RVMD has 215M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over RVMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
RVMD Net Leverage
RVMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
RVMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.3 | Neutral |
| Stochastic | 22.2 | Neutral |
RVMD's weekly RSI is 49 (neutral) and its Stochastic is 22 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
RVMD PE vs Healthcare Sector
RVMD has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
RVMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $190.8 | 7.6% below |
| 20 week MA | $194.8 | 9.5% below |
| 50 week MA | $147.8 | 19% above |
| 100 week MA | $95.6 | 85% above |
| 200 week MA | $64.3 | 174% above |
RVMD has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 174% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over RVMD on trend strength, trading above more of its moving averages.
RVMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.3 | $42.6 | +51% |
| 2021 | $42.6 | $27.6 | -35% |
| 2022 | $27.6 | $22.0 | -20% |
| 2023 | $22.0 | $28.7 | +30% |
| 2024 | $28.7 | $44.2 | +54% |
| 2025 | $44.2 | $80.8 | +83% |
| 2026 YTD | $80.8 | $176.4 | +118% |
RVMD has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.